Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Rhinitis, Allergic | 11 | 2021 | 704 | 2.94 | Why? |
| Desensitization, Immunologic | 7 | 2021 | 574 | 1.73 | Why? |
| Anaphylaxis | 5 | 2021 | 940 | 1.45 | Why? |
| Sinusitis | 7 | 2021 | 649 | 1.32 | Why? |
| Allergens | 5 | 2021 | 728 | 1.21 | Why? |
| Rhinitis | 4 | 2021 | 626 | 1.11 | Why? |
| Sublingual Immunotherapy | 3 | 2020 | 88 | 1.00 | Why? |
| Budesonide | 2 | 2021 | 192 | 0.94 | Why? |
| Histamine Antagonists | 2 | 2020 | 203 | 0.86 | Why? |
| Otolaryngology | 3 | 2021 | 1917 | 0.73 | Why? |
| Asthma | 6 | 2021 | 4383 | 0.66 | Why? |
| Hypersensitivity | 5 | 2021 | 1137 | 0.64 | Why? |
| Common Cold | 1 | 2021 | 645 | 0.57 | Why? |
| Mucous Membrane | 1 | 2017 | 305 | 0.57 | Why? |
| Nasal Polyps | 3 | 2021 | 221 | 0.45 | Why? |
| Adjuvants, Immunologic | 3 | 2018 | 1709 | 0.44 | Why? |
| TRPA1 Cation Channel | 2 | 2021 | 82 | 0.42 | Why? |
| Allergists | 3 | 2021 | 266 | 0.42 | Why? |
| Vaccines | 2 | 2021 | 3692 | 0.40 | Why? |
| Conjunctivitis, Allergic | 2 | 2020 | 94 | 0.36 | Why? |
| Histamine H1 Antagonists | 2 | 2019 | 79 | 0.35 | Why? |
| Olfaction Disorders | 3 | 2021 | 3704 | 0.35 | Why? |
| Epinephrine | 2 | 2021 | 323 | 0.35 | Why? |
| NF-E2-Related Factor 2 | 2 | 2021 | 373 | 0.33 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.32 | Why? |
| Adrenal Cortex Hormones | 5 | 2021 | 6537 | 0.26 | Why? |
| Psychophysics | 1 | 2021 | 56 | 0.22 | Why? |
| Drug Administration Routes | 2 | 2018 | 106 | 0.21 | Why? |
| TRPV Cation Channels | 1 | 2021 | 88 | 0.20 | Why? |
| Spices | 1 | 2020 | 130 | 0.20 | Why? |
| Ambroxol | 1 | 2018 | 45 | 0.19 | Why? |
| Anti-Allergic Agents | 2 | 2020 | 167 | 0.19 | Why? |
| Calcineurin Inhibitors | 1 | 2020 | 218 | 0.19 | Why? |
| Taste Disorders | 2 | 2021 | 1720 | 0.19 | Why? |
| Expectorants | 1 | 2018 | 95 | 0.18 | Why? |
| Nitric Oxide Synthase Type III | 1 | 2018 | 87 | 0.18 | Why? |
| Stem Cell Niche | 1 | 2017 | 16 | 0.17 | Why? |
| Lipid A | 1 | 2017 | 32 | 0.17 | Why? |
| Chronic Disease | 4 | 2021 | 5139 | 0.17 | Why? |
| Cell Self Renewal | 1 | 2017 | 55 | 0.17 | Why? |
| Humans | 45 | 2022 | 930598 | 0.16 | Why? |
| Respiratory Hypersensitivity | 1 | 2018 | 103 | 0.16 | Why? |
| Immunoglobulin E | 1 | 2020 | 557 | 0.16 | Why? |
| Polyethylene Glycols | 1 | 2021 | 574 | 0.16 | Why? |
| Th2 Cells | 1 | 2020 | 680 | 0.16 | Why? |
| Otolaryngologists | 1 | 2021 | 533 | 0.15 | Why? |
| Decision Support Systems, Clinical | 2 | 2018 | 551 | 0.15 | Why? |
| Diagnostic Techniques and Procedures | 1 | 2018 | 265 | 0.15 | Why? |
| Biological Products | 2 | 2021 | 2331 | 0.15 | Why? |
| Respiratory Physiological Phenomena | 1 | 2017 | 157 | 0.15 | Why? |
| Drug Dosage Calculations | 1 | 2017 | 243 | 0.15 | Why? |
| Administration, Inhalation | 1 | 2021 | 1647 | 0.14 | Why? |
| Mobile Applications | 3 | 2019 | 3032 | 0.14 | Why? |
| Complement Activation | 1 | 2021 | 949 | 0.14 | Why? |
| Ophthalmologists | 1 | 2020 | 401 | 0.13 | Why? |
| Eosinophils | 1 | 2020 | 848 | 0.13 | Why? |
| Telemedicine | 3 | 2020 | 25032 | 0.12 | Why? |
| Immune Tolerance | 1 | 2017 | 608 | 0.12 | Why? |
| Lymph Nodes | 1 | 2018 | 1060 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Stem Cells | 1 | 2017 | 595 | 0.11 | Why? |
| Smartphone | 2 | 2019 | 1840 | 0.11 | Why? |
| Germany | 3 | 2021 | 9196 | 0.10 | Why? |
| Respiratory Tract Diseases | 1 | 2018 | 1061 | 0.10 | Why? |
| Consensus | 2 | 2021 | 6345 | 0.10 | Why? |
| Diet | 1 | 2020 | 2052 | 0.09 | Why? |
| Cost of Illness | 1 | 2018 | 1903 | 0.08 | Why? |
| Drug Delivery Systems | 1 | 2017 | 1365 | 0.08 | Why? |
| Surgeons | 1 | 2021 | 2233 | 0.08 | Why? |
| Nanoparticles | 1 | 2017 | 2040 | 0.07 | Why? |
| Societies, Medical | 1 | 2021 | 6907 | 0.07 | Why? |
| Animals | 7 | 2018 | 78931 | 0.07 | Why? |
| Immunotherapy | 1 | 2018 | 2421 | 0.07 | Why? |
| Treatment Outcome | 3 | 2018 | 51732 | 0.06 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.06 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Evidence-Based Practice | 2 | 2018 | 693 | 0.06 | Why? |
| Solvents | 1 | 2002 | 139 | 0.06 | Why? |
| Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.06 | Why? |
| Brassica | 1 | 2021 | 66 | 0.05 | Why? |
| Antioxidants | 2 | 2021 | 1593 | 0.05 | Why? |
| Taste Perception | 1 | 2021 | 79 | 0.05 | Why? |
| Administration, Ophthalmic | 1 | 2020 | 53 | 0.05 | Why? |
| Fermentation | 1 | 2020 | 156 | 0.05 | Why? |
| Methanol | 1 | 2002 | 149 | 0.05 | Why? |
| Olfactory Perception | 1 | 2021 | 93 | 0.05 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Subcutaneous Absorption | 1 | 2018 | 4 | 0.05 | Why? |
| Visual Analog Scale | 1 | 2019 | 151 | 0.05 | Why? |
| Interleukin-1 | 1 | 2002 | 438 | 0.05 | Why? |
| Adrenergic beta-Agonists | 1 | 2018 | 93 | 0.05 | Why? |
| Disease Resistance | 1 | 2020 | 236 | 0.05 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.04 | Why? |
| Information Technology | 1 | 2021 | 278 | 0.04 | Why? |
| Vegetables | 1 | 2020 | 340 | 0.04 | Why? |
| Octamer Transcription Factor-3 | 1 | 2017 | 17 | 0.04 | Why? |
| Nonprescription Drugs | 1 | 2018 | 78 | 0.04 | Why? |
| Nestin | 1 | 2017 | 12 | 0.04 | Why? |
| Adult | 10 | 2021 | 244371 | 0.04 | Why? |
| Neurogenesis | 1 | 2017 | 64 | 0.04 | Why? |
| Intermediate Filaments | 1 | 2017 | 77 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.04 | Why? |
| Academies and Institutes | 1 | 2020 | 539 | 0.04 | Why? |
| Enzyme Activation | 1 | 2018 | 425 | 0.04 | Why? |
| Injections, Subcutaneous | 1 | 2018 | 647 | 0.04 | Why? |
| Male | 7 | 2021 | 367725 | 0.04 | Why? |
| Tablets | 1 | 2017 | 219 | 0.04 | Why? |
| Interleukin-8 | 1 | 2002 | 964 | 0.04 | Why? |
| Pollen | 1 | 2017 | 137 | 0.04 | Why? |
| Administration, Intranasal | 1 | 2020 | 1132 | 0.04 | Why? |
| Markov Chains | 1 | 2018 | 502 | 0.04 | Why? |
| Cell Lineage | 1 | 2017 | 241 | 0.04 | Why? |
| Injections, Intramuscular | 1 | 2018 | 800 | 0.04 | Why? |
| Photography | 1 | 2018 | 255 | 0.04 | Why? |
| Efficiency | 1 | 2019 | 420 | 0.04 | Why? |
| Quality-Adjusted Life Years | 1 | 2018 | 511 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2020 | 1136 | 0.03 | Why? |
| Nasal Mucosa | 1 | 2002 | 1218 | 0.03 | Why? |
| Down-Regulation | 1 | 2021 | 1416 | 0.03 | Why? |
| Phosphorylation | 1 | 2018 | 1060 | 0.03 | Why? |
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 290 | 0.03 | Why? |
| United States | 1 | 2021 | 46150 | 0.03 | Why? |
| Rats, Sprague-Dawley | 1 | 2017 | 987 | 0.03 | Why? |
| Costs and Cost Analysis | 1 | 2018 | 694 | 0.03 | Why? |
| Comorbidity | 1 | 2018 | 34796 | 0.03 | Why? |
| Europe | 2 | 2020 | 12702 | 0.03 | Why? |
| Aged | 5 | 2021 | 215776 | 0.03 | Why? |
| Up-Regulation | 1 | 2021 | 2249 | 0.03 | Why? |
| Administration, Oral | 1 | 2020 | 2340 | 0.03 | Why? |
| User-Computer Interface | 1 | 2018 | 1068 | 0.03 | Why? |
| Nitric Oxide | 1 | 2018 | 769 | 0.03 | Why? |
| Disease Management | 2 | 2020 | 6841 | 0.03 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
| Recovery of Function | 1 | 2021 | 2461 | 0.03 | Why? |
| Practice Guidelines as Topic | 3 | 2020 | 15421 | 0.03 | Why? |
| Female | 6 | 2021 | 380317 | 0.03 | Why? |
| Breast Feeding | 1 | 2021 | 1585 | 0.03 | Why? |
| Oxidative Stress | 1 | 2021 | 2050 | 0.02 | Why? |
| Rats | 1 | 2017 | 2764 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2022 | 51949 | 0.02 | Why? |
| Phenotype | 1 | 2019 | 4037 | 0.02 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.02 | Why? |
| Seasons | 1 | 2020 | 4071 | 0.02 | Why? |
| Patient Care Team | 1 | 2021 | 3556 | 0.02 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Clinical Protocols | 1 | 2017 | 2734 | 0.02 | Why? |
| Symptom Assessment | 1 | 2019 | 4967 | 0.02 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.02 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.02 | Why? |
| Transcriptome | 1 | 2017 | 3466 | 0.02 | Why? |
| Prostaglandins E | 1 | 2002 | 7 | 0.02 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.02 | Why? |
| Young Adult | 3 | 2019 | 93724 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2017 | 3755 | 0.02 | Why? |
| Computer Simulation | 1 | 2018 | 4982 | 0.02 | Why? |
| Exudates and Transudates | 1 | 2002 | 92 | 0.01 | Why? |
| Triage | 1 | 2021 | 7151 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.01 | Why? |
| Child | 2 | 2019 | 70012 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Adolescent | 2 | 2019 | 86841 | 0.01 | Why? |
| Infant, Newborn | 1 | 2019 | 23105 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2021 | 43792 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Infant | 1 | 2019 | 30274 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.01 | Why? |
| Child, Preschool | 1 | 2019 | 36283 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2019 | 15909 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Risk Factors | 1 | 2019 | 71621 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2019 | 88759 | 0.01 | Why? |
| Time Factors | 1 | 2002 | 31397 | 0.00 | Why? |
Klimek's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(534)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_